Laatste nieuws & blog
-
We’re proud and excited to join forces with SUPERP to accelerate our mission!
We’re proud and excited to join forces with SUPERP to accelerate our mission!Superp’s expertise helps strengthen the foundation we’re building for cheaper, faster, and smarter trials for patients with rare cancer. Enabling real impact takes more than science alone: it takes a shared ambition, strong infrastructures, and trusted partners.Thanks for standing with us! Read more…
-
On a mission: effective treatments for rare cancer patients
On a mission: effective treatments for rare cancer patients. One year of progress.On the 9th of October, Stichting Yamicc celebrated its first official anniversary! A milestone, and a great moment to reflect.We are laying the foundation to make clinical trials for rare cancers cheaper, faster, and more effective. Here’s a glimpse of what has happened…
-
Yamicc Explained: Why rare cancers need a different approach
Why rare cancers need a different approachOne in two people get cancer.One in five cancer patients is diagnosed with a rare form of the disease.But while oncology has advanced rapidly, traditional research models still fall short for rare cancer patients, because they weren’t built for this kind of complexity.Rare cancers are often biologically diverse and…
-
Yamicc Explained: What we do (and why it is different)
Yamicc Explained: What we do (and why it is different)Yamicc is here to help change the system, not just the science.As an independent foundation, we stimulate, coordinate and facilitate smarter data collection by more clinical trials for rare cancers.We bring together doctors, hospitals, researchers and data experts, and build a new infrastructure that’s still too…
-
Yamicc Explained: Why we’re building what we’re building
In recent decades, treatment and research in oncology have made huge strides. But for people with a rare form of cancer, survival chances still lag far behind.Finding effective treatments is one of the hardest challenges in these cancers, and not just because of biology. It’s a systemic issue.Patient numbers are low, collaboration is limited, and…
-
Glioblastoma Awareness Week
Glioblastoma is a rare and aggressive brain tumour with very limited treatment options, and far too little progress. At Yamicc, we work to change that: for patients and their loved ones, hope and time is everything.As part of our mission in finding more effective treatments for rare cancers, we support the ReDiReCCT-GB trial. This trial…
-
RIFF donates to Yamicc
RIFF donates €5000,- to Yamicc. Thanks for your support in finding more effective rare cancer treatmentsA heartfelt thank you to Riff and Eline Sijtsma-van Aken for your generous contribution, a special and meaningful cheque for Yamicc! Above all, thank you for choosing to stand with us at this early stage.One out of five cancer patients…
-
Yamicc team update
We’re thrilled to introduce Lisa de Man as our new Head of Legal!With a strong track record in commercial contracts, European law, compliance, and tech, Lisa joins us after working for several years as Legal Counsel at Mendix in Singapore and Rotterdam.At Yamicc, she will shape and safeguard the legal frameworks that support our mission:…